within Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01F_MonoclonalAntibodiesAndAntibodyDrugConjugates.L01FE02_Panitumumab;
model Panitumumab 
   extends Pharmacolibrary.Drugs.ATC.L.L01FE02;

  annotation(Documentation(
    info ="<html><body><p>Panitumumab is a fully human monoclonal antibody targeting the epidermal growth factor receptor (EGFR). It is primarily used for the treatment of metastatic colorectal cancer, especially in patients with wild-type KRAS status. It is approved for medical use and is administered via intravenous infusion.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in adult cancer patients (metastatic colorectal cancer), generally similar across sexes. Values are based on population pharmacokinetic analyses.</p><h4>References</h4><ol><li><p>Ketzer, S, et al., &amp; Guchelaar, HJ (2018). Clinical Pharmacokinetics and Pharmacodynamics of the Epidermal Growth Factor Receptor Inhibitor Panitumumab in the Treatment of Colorectal Cancer. <i>Clinical pharmacokinetics</i> 57(4) 455–473. DOI:<a href=&quot;https://doi.org/10.1007/s40262-017-0590-9&quot;>10.1007/s40262-017-0590-9</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28853050/&quot;>https://pubmed.ncbi.nlm.nih.gov/28853050</a></p></li><li><p>Yang, BB, et al., &amp; Kennecke, H (2013). Pharmacokinetics of Irinotecan With and Without Panitumumab Coadministration in Patients With Metastatic Colorectal Cancer. <i>Clinical pharmacology in drug development</i> 2(3) 205–212. DOI:<a href=&quot;https://doi.org/10.1002/cpdd.35&quot;>10.1002/cpdd.35</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27121781/&quot;>https://pubmed.ncbi.nlm.nih.gov/27121781</a></p></li><li><p>Doi, T, et al., &amp; Ohtsu, T (2009). Safety and pharmacokinetics of panitumumab in Japanese patients with advanced solid tumors. <i>International journal of clinical oncology</i> 14(4) 307–314. DOI:<a href=&quot;https://doi.org/10.1007/s10147-008-0855-2&quot;>10.1007/s10147-008-0855-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19705240/&quot;>https://pubmed.ncbi.nlm.nih.gov/19705240</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Panitumumab;
